Does OptumRx Cover Wegovy? 2026 Coverage, Prior Authorization & Cost
By The RX Index Editorial Team ·
The RX Index is a pricing intelligence and comparison resource for GLP-1 telehealth providers. To write this, we read OptumRx’s 2026 formularies, UnitedHealthcare’s published prior authorization rules, NovoCare’s pricing pages, and current federal coverage policy. We may earn a commission if you start a program through some links — it never changes the coverage facts on this page. This is educational information, not medical advice.
Does OptumRx cover Wegovy? Yes — it can. But it is not automatic, and “yes” depends on your specific plan. On the OptumRx 2026 standard formularies we reviewed (including the Select Standard list), Wegovy is listed as a covered Tier 2 drug. Right next to it sit three little tags: PA (prior authorization), QL (quantity limit), and ++. That last symbol is the one that trips up thousands of people. In OptumRx’s own legend, ++ means “Benefit design options — coverage is determined by your prescription medication benefit plan.” In plain English: your employer or plan sponsor gets the final vote on whether weight-loss drugs are even part of your benefit.
So three things decide your answer: (1) does your plan include weight-loss drug coverage, (2) do you meet the prior authorization rules (usually a BMI of 30+, or 27+ with a weight-related condition), and (3) which reason you’re prescribed it for. Below, we’ll show you how to read your own coverage in about one phone call — and exactly what to do whether you’re covered, excluded, or already denied.
What this page covers (and what it can’t):
- Last verified: .
- Sources checked: OptumRx 2026 formulary + symbol legend, UnitedHealthcare 2026 weight-loss prior authorization rules, the CMS Medicare GLP-1 Bridge, NovoCare pricing pages, the Wegovy FDA label, and HealthCare.gov / U.S. Department of Labor appeal rules.
- Applies to: OptumRx prescription benefits, including UnitedHealthcare plans that use OptumRx, for the Wegovy pen and the Wegovy pill.
- Does not replace: your own plan documents, your doctor’s advice, or a call to OptumRx. Your exact coverage is set by your plan.
Have your insurance card handy and want a plan-specific answer right now?
Ro offers a free GLP-1 insurance coverage check: you enter your card info, Ro contacts your insurer, and you get a report showing whether Wegovy is covered, what prior authorization is needed, and an estimated copay — before you commit to anything. Best if you have commercial insurance and want a real answer fast.
Check your Wegovy coverage free →The OptumRx Wegovy Coverage Decoder
Most people land here staring at a confusing word in their OptumRx app or a denial letter. So before anything else, find your situation in the table below. This is the part you’ll want to screenshot. We built it by combining what OptumRx, UnitedHealthcare, NovoCare, and federal rules actually say — facts that normally live across a dozen different pages.
| What your OptumRx result says | What it probably means | Your best next move |
|---|---|---|
| Wegovy shows as Tier 2 with PA, QL, ++ | It can be covered on that formulary, but approval still depends on your benefit design, a prior authorization, and quantity limits | Confirm your plan covers weight-loss drugs, then have your prescriber send the PA with the right documents |
| “Prior authorization required” | Not a denial — OptumRx just needs clinical info from your prescriber before it will pay | Get your doctor to submit your BMI, any weight-related condition, and your lifestyle-effort notes |
| “Not covered” or “Excluded” | Your plan likely doesn’t include weight-loss medications as a benefit — a different issue than not qualifying | Confirm the exact reason in writing, then check the appeal and cash-pay options below |
| “Quantity limit” message | Your plan covers it but caps how much you get per fill | Ask your prescriber to match the prescription to the covered quantity, or request a limit exception |
| Your employer requires a program | Some plans only cover GLP-1s if you enroll in a specific weight-management program first | Call the number on your card or ask HR which program is required |
| You were approved and renewal is due | Reauthorization usually needs proof the drug is working — often 5% weight loss from your starting weight | Track your starting and current weight, and keep your lifestyle-effort records |
| You have Medicare, Medicaid, or TRICARE | Different rules apply — weight-loss coverage is limited, and the manufacturer savings card is off-limits | Use your plan’s pathway first (see the Medicare GLP-1 Bridge section below) |
| Denied and you still want brand-name Wegovy | Cash-pay is far cheaper than the old list price, though still real money | Compare an appeal vs. self-pay before you give up on treatment |
How do I check my OptumRx Wegovy coverage?
Quick answer: The fastest way to check your OptumRx Wegovy coverage is to log into your OptumRx account or app, search “Wegovy,” and read whether the result says covered, prior authorization required, quantity limit, not covered, or excluded. If the result is unclear, call the number on your member ID card and ask the four specific questions below.
In the OptumRx app or website
Use the drug pricing/search tool, type in Wegovy, and pick your form (pen or pill). Screenshot the result — capture the drug name, the form, the tier, every symbol (PA, QL, ST, ++), the “covered / not covered / excluded” wording, your plan name, and the date. That screenshot makes every later conversation faster.
On the phone, read this to the rep
“Can you tell me whether the Wegovy pen and the Wegovy tablet are covered under my exact prescription benefit plan? Are weight-loss medications excluded? What are the prior authorization rules — BMI, conditions, step therapy? Is there a quantity limit? And does a cardiovascular or liver (MASH) reason use a different rule?”
Then ask for the answer in writing. A coverage determination on paper protects you if anything changes later.
Want a shortcut? If you’d rather not sit on hold, Ro’s free coverage check contacts your insurer for you and returns a report with the prior authorization details and an estimated copay. Commercial insurance only — not Medicare, Medicaid, or TRICARE.
Does OptumRx cover Wegovy in 2026?
Quick answer: OptumRx can cover Wegovy in 2026, but coverage is not universal — it depends on your plan’s benefit design plus prior authorization approval. On the OptumRx 2026 standard formularies we reviewed, Wegovy is listed as a Tier 2 drug with prior authorization and a quantity limit. That’s a coverage signal. It is not a guarantee for every OptumRx member or every OptumRx-administered plan.
Here’s the catch most pages won’t admit: OptumRx can list Wegovy on a standard formulary, and your specific plan can still make it hard — or impossible — to get. The reason is that “++” benefit-design tag, plus prior authorization and quantity limits. There is no clean, universal yes or no. We know that’s a less satisfying answer. But it’s the useful one, because it tells you what to check before you wait weeks on a prior authorization your plan was never going to approve.
The two layers that decide everything
Think of OptumRx coverage as two separate gates. You have to clear both.
Layer 1 — The formulary
This is the master list of covered drugs that OptumRx and its pharmacy committee maintain. Wegovy is on it (Tier 2). Good start.
Layer 2 — Your benefit design
This is what your employer or plan sponsor chose to cover. Many employers leave weight-loss drugs off the benefit to save money. When that happens, Wegovy can be on the formulary and still come back “not covered” for you. That’s exactly what the “++” symbol warns about. OptumRx even spells this out: the formulary is not a complete description of your benefits, and your plan documents decide what’s actually covered.
This single distinction — on the list vs. covered for you — is the answer to the question thousands of frustrated people are really asking. It’s not always that you don’t qualify. It’s that your plan may not include the benefit.
What we found in OptumRx’s actual 2026 formulary
On the OptumRx 2026 formulary booklets we reviewed, the Wegovy row reads: Tier 2 · PA · QL · ++. In plain words: a mid-level cost tier, prior authorization required, a cap on quantity per fill, and coverage that ultimately depends on your benefit plan.
One more note for anyone comparing options at open enrollment: on the standard list we checked, OptumRx kept Wegovy (Tier 2, PA, QL) and the Zepbound subcutaneous auto-injector (Tier 2, PA, QL). The Zepbound vial form was excluded on the books we reviewed — so check your own plan for the exact product.
What do PA, QL, ST, and ++ mean on your OptumRx formulary?
Quick answer: On an OptumRx drug list, PA means prior authorization (your doctor must send clinical info before coverage), QL means quantity limit (a cap on how much you get per fill), ST means step therapy (try another drug first), and ++ means “benefit design options” (your plan decides coverage). These tiny symbols matter because Wegovy can appear on a formulary and still need plan-specific approval before anyone pays for it.
PA — Prior authorization
A “PA” tag does not mean denied. It means OptumRx needs more information from your prescriber before it will cover the drug. Your doctor submits your details, and OptumRx checks them against the plan’s rules.
QL — Quantity limit
Your plan limits how much it will cover per fill — for example, a set number of pens or tablets per month. If you need more, your prescriber can request a quantity-limit exception.
ST — Step therapy
If you see “ST,” your plan may want you to try another covered medication first before it pays for Wegovy. Don’t assume step therapy applies unless your own result shows it. On the OptumRx Select Standard Wegovy row we checked, the tags were PA, ++, and QL — not ST — but your plan can differ.
++ — The symbol that explains the confusion
This is the one almost everyone misses. In OptumRx’s formulary legend, ++ stands for “Benefit design options — coverage is determined by your prescription medication benefit plan.” It’s the formal way of saying: your employer’s plan gets the last word. If your plan left weight-loss drugs off the benefit, the “++” is the reason your covered-looking drug still says “not covered.”
What are OptumRx’s prior authorization requirements for Wegovy?
Quick answer: For UnitedHealthcare commercial plans that use this optional weight-loss prior authorization program — meaning the employer chose to cover weight-loss drugs — Wegovy’s 2026 rules require lifestyle effort plus a BMI of 30 or higher, or 27 or higher with a weight-related condition, with an initial approval lasting 5 months. These are the published rules for UHC plans; state mandates, federal rules, your specific benefit design, and other utilization programs can still change the result.
We read UnitedHealthcare’s actual 2026 weight-loss prior authorization criteria (effective May 1, 2026). Here’s what your prescriber has to show for an initial Wegovy approval:
| What’s checked | What your prescriber documents |
|---|---|
| Why you need it | Weight loss/appetite suppression -- or Wegovy for heart-risk reduction if you have established heart disease -- or the Wegovy injection for MASH (a liver condition) with moderate-to-advanced fibrosis (stage F2 or F3) |
| Lifestyle effort | You're using it alongside diet/calorie changes, exercise, behavioral support, or a community-based program |
| Your BMI | A BMI of 30 or higher -- OR a BMI of 27 or higher plus a weight-related condition like high cholesterol, high blood pressure, type 2 diabetes, or sleep apnea |
| Age | The Wegovy injection is listed for ages 12 and up; the Wegovy tablet falls under the program's 'all other medications' rule of over 16. (The FDA label lists Wegovy tablets for adults.) |
| How long it lasts | Initial approval is 5 months for the Wegovy pen or pill |
A “weight-related condition” — a health problem linked to extra weight, like high blood pressure or type 2 diabetes — is what lets people with a BMI between 27 and 29.9 qualify. So your starting paperwork isn’t just a number — it’s the number plus the diagnosis, documented in your chart.
Already on Wegovy? Here’s what renewal needs
To renew (reauthorize) Wegovy on these UHC rules, you generally need to show at least 5% weight loss from your starting weight and that you’re still doing the lifestyle work. Clear that bar, and renewal is typically approved for 12 months. What this means for you: from day one, write down your starting weight. If your chart never recorded a baseline, a renewal denial can come down to missing math, not missing progress.
Your Wegovy prior authorization prep checklist
Bring these to your prescriber before the PA goes in. A missing item is the most common reason a covered drug turns into a denial:
- Current height and weight (and your BMI)
- Your starting weight, recorded in your chart
- The diagnosis/reason (weight management, heart-risk reduction, or MASH)
- Any weight-related conditions (high blood pressure, high cholesterol, type 2 diabetes, sleep apnea)
- Notes on diet, exercise, or a program you’ve tried
- Your heart-disease history, if you’re using the cardiovascular pathway
- Your most recent denial letter, if you’ve already been turned down
How long does approval take? Electronic prior authorizations can move quickly, while incomplete ones drag on. If you go through a telehealth concierge, Ro says its insurance route typically takes 1 to 3 weeks.
If your plan covers weight-loss drugs and you’d rather not chase the paperwork yourself
When a Ro-affiliated provider writes your prescription through the Ro Body membership, Ro’s insurance concierge verifies your benefits and submits the prior authorization for you — and if your insurer denies one medication, your provider can check whether another FDA-approved option is a fit and resubmit. Ro’s membership is cash-pay and separate from the medication. Not available for Medicare, Medicaid, or TRICARE; FEHB members are accepted.
See if Ro can handle your Wegovy prior authorization →Why does OptumRx say “not covered” when Wegovy is on the formulary?
Quick answer: OptumRx can show “not covered” even when Wegovy is on the formulary because your plan may exclude weight-loss drugs, your prior authorization paperwork may be incomplete, or your chart may be missing the BMI or condition the plan looks for. The most important first step is to get the exact reason in writing before you change drugs or pay cash — because the fix is completely different depending on the reason.
Here are the five reasons this happens, from most common to least:
- Your plan excludes weight-loss drugs. This is the big one. One OptumRx-administered plan can cover Wegovy while another leaves it off entirely. That’s the “++” symbol in action.
- The prior authorization packet was incomplete. Your doctor may have sent the prescription but not the specific clinical proof the plan requires. The drug looks covered; the paperwork just wasn’t finished.
- Your BMI or condition wasn’t documented. This one stings, but don’t read it as “you don’t qualify.” Read it as “your chart didn’t record what the plan was looking for.” Often fixable with updated notes.
- Renewal evidence was missing. If you were approved before and got denied at renewal, it’s usually the 5%-weight-loss proof or the lifestyle documentation that’s missing.
- Your employer added a required program. Some plans only cover GLP-1s after you enroll in a specific weight-management program. Skip the program, and the drug gets blocked — not because of you, but because of a plan rule.
What should I do if OptumRx denied Wegovy?
Quick answer: Get the denial reason in writing, compare it to your plan’s prior authorization rules, then either resubmit with the missing documents or file an appeal if the denial is fixable. Under federal rules, you generally have 180 days from the denial notice to file an internal appeal, and you can request an external (independent) review if the internal appeal fails.
The 4-step path
- Get the exact denial reason. Call OptumRx or read your letter and pin down which it is: Was the drug excluded from your plan? Was the PA denied for missing info? Was the diagnosis not accepted? Was it a BMI or condition issue? A quantity limit? A required program? You can’t fix what you can’t name.
- Save everything. Keep your denial letters, your Explanation of Benefits, copies of any appeal, your doctor’s letters, and notes from every phone call (date, name, what was said). This paper trail is your leverage.
- Route the denial. Match your reason to the move in the table below.
- Know your clock. Denied health claims generally get at least 180 days to appeal, and your denial notice must explain why you were denied and how to appeal. Don’t sit on it.
| Denial reason | Your best next move |
|---|---|
| “Drug not covered / excluded” | Confirm your plan documents and employer benefit. Appeal only if there’s a covered reason (like heart-risk reduction or MASH) or a plan error. |
| “PA criteria not met” | Have your prescriber resubmit with your BMI, condition, lifestyle notes, and diagnosis. |
| “Missing information” | Send the specific clinical info that was left out. |
| “Renewal denied” | Submit your starting and current weight plus proof you’ve continued lifestyle changes. |
| “Urgent health situation” | Ask about an expedited (fast) appeal and external review timelines. |
One honest note on exclusions
If it’s a true weight-loss benefit exclusion, don’t burn weeks blindly appealing a benefit your plan simply doesn’t include. First check whether a covered reason — like cardiovascular risk reduction or MASH — applies to you, or whether the letter shows a plan error you can challenge. If none of those fit, the cash-pay options below are your fastest route.
Not sure whether to fight the denial or switch to a cash-pay option?
Answer a few quick questions and we’ll map your exact next step — appeal, resubmit, call your employer plan, or compare self-pay prices. Right move if your result is confusing or your PA just got denied.
Get your personalized next-step plan (free, 60 seconds) →How much does Wegovy cost with OptumRx?
Quick answer: Your Wegovy cost with OptumRx depends on your plan’s tier, deductible, and copay — but if your plan covers it, the manufacturer savings card can bring eligible commercially-insured patients to as little as $25 a month. If your plan doesn’t cover it, self-pay through NovoCare runs about $149 to $399 a month depending on the dose and form.
If OptumRx covers your Wegovy
Your final cost depends on your tier, whether you’ve met your deductible, your copay or coinsurance, and whether your plan allows the manufacturer savings card. Wegovy usually sits in a higher specialty-style tier, so the sticker can look scary — until the savings card kicks in.
The Wegovy Savings Card: if you have commercial (non-government) insurance that covers Wegovy, NovoCare says eligible patients may pay as little as $25 a month, with savings capped at $100 per monthly supply. You enroll on NovoCare’s site, get the card, and hand it to your pharmacist with your insurance card. Important: Medicare, Medicaid, and TRICARE members cannot use the manufacturer savings card.
If OptumRx does NOT cover your Wegovy
Here’s every legitimate path in one place, including the ones we don’t earn a dime from. Prices verified June 2026 — always confirm the current number for your dose before you buy.
| Path | Who it fits | Price |
|---|---|---|
| Covered + Wegovy Savings Card | Commercial plan that covers Wegovy | As little as $25/month (max $100/month savings) |
| NovoCare self-pay — Wegovy pill | Needle-averse; cash-pay | From $149/month for 1.5 mg and 4 mg (4 mg rises to $199 after Aug 31, 2026); 9 mg and 25 mg are $299/month |
| NovoCare self-pay — Wegovy pen | Excluded plans; cash-pay | $199/month for 0.25 mg and 0.5 mg starter doses (two fills, through June 30, 2026), then $349/month standard; Wegovy HD 7.2 mg $399/month |
| TrumpRx (trumprx.gov) | Cash-pay, no insurance or income test | About $349/month standard pen; about $149/month pill |
| Costco (via Sesame, Novo partnership) | Costco members paying cash | About $349/month injection; $149/month pill |
| Retail pharmacy, no insurance | Same-day local pickup only | About $1,349/month list price, before any discounts |
If needles are your sticking point, the Wegovy pill is an FDA-approved oral GLP-1 for weight loss (approved December 2025) at one of the cheapest self-pay entry points. Eli Lilly’s Foundayo (orforglipron) became the second oral GLP-1 when the FDA approved it in April 2026.
Want brand-name Wegovy at the best available cash price?
Ro offers FDA-approved Wegovy (pen and pill) at cash-pay prices that match NovoCare and TrumpRx, plus coaching and dose support — with the Ro Body membership billed separately. Prefer to pick your own doctor or you’re a Costco member? Sesame’s FDA-approved formulary and Costco pricing may fit better — just note Sesame’s subscription is billed every 28 days, with medication priced separately.
Does OptumRx cover the Wegovy pill the same as the Wegovy pen?
Quick answer: Not always — coverage for the Wegovy pill versus the pen depends on your plan’s formulary and prior authorization rules, even though UnitedHealthcare’s 2026 criteria include both the injection and the tablet. Your member portal still has to confirm the exact form and dose.
Here’s what to check:
- Does your result say Wegovy tablet/pill, Wegovy pen/injection, or just “WEGOVY”?
- Does the prior authorization apply to both forms?
- Does your plan cover one formulation but not the other?
- Does your pharmacy actually stock the specific form?
For reference, the FDA label lists both the injection and the tablet with separate dosing instructions, so they’re treated as distinct products at the pharmacy counter even though both are semaglutide. See also: Wegovy pill vs. injection: which form is right for you?
Does OptumRx cover Wegovy for weight loss, heart disease, MASH, Medicare, or CHAMPVA?
Quick answer: Wegovy coverage can shift depending on why it’s prescribed and which plan you have — UnitedHealthcare’s commercial criteria cover Wegovy for weight loss, for heart-risk reduction with established heart disease, and (for the injection) for the liver condition MASH, while government plans follow different and stricter rules. The reason you’re prescribed it can open a coverage door that weight loss alone doesn’t.
Wegovy for chronic weight management
Per the FDA label, Wegovy is used with a reduced-calorie diet and more physical activity for long-term weight management in adults with obesity, or who are overweight with at least one weight-related condition. This is the most common reason — and the one most subject to your plan’s benefit design.
Wegovy for heart-risk reduction
If you have established cardiovascular disease (for example, a prior heart attack, stroke, or peripheral arterial disease), UnitedHealthcare’s criteria include Wegovy to reduce the risk of major heart events. This matters a lot: if your plan excludes weight-loss drugs but you have heart disease, ask your doctor whether the cardiovascular reason applies to you. It can open a coverage path that “weight loss” cannot.
Wegovy injection for MASH
UHC’s 2026 criteria also include the Wegovy injection for MASH — metabolic dysfunction-associated steatohepatitis, a liver condition — with moderate-to-advanced fibrosis (stage F2 or F3). It’s a narrower, condition-specific pathway, but a real one.
Medicare (and a big change starting July 2026)
Today, OptumRx Medicare plans don’t cover Wegovy for weight loss — Medicare has long been barred from covering weight-loss drugs. But that changes temporarily. Through the Medicare GLP-1 Bridge, a CMS demonstration running July 1, 2026 through December 31, 2027, eligible Medicare Part D members can get certain GLP-1s — including Wegovy (injection and tablets), the Zepbound KwikPen, and Foundayo — for a flat $50 a month when prescribed for weight management.
To qualify, you must be enrolled in a Part D plan and meet one of three clinical pathways (measured at the time you first started GLP-1 therapy):
- A BMI of 35 or higher (no other condition needed), or
- A BMI of 30 or higher with heart failure with preserved ejection fraction, uncontrolled high blood pressure (on at least two BP medications), or chronic kidney disease stage 3a or above, or
- A BMI of 27 or higher with prediabetes, a previous heart attack, a previous stroke, or symptomatic peripheral artery disease.
Prior authorization is required, and the $50 copay runs outside your regular Part D benefit — so it won’t count toward your deductible or out-of-pocket cap. CMS says you don’t need to register now — prior authorization requests won’t be accepted before July 1, 2026. Check CMS.gov for the latest. See also: Medicare GLP-1 Bridge: full guide →
Medicaid
Medicaid coverage is set state by state, and for weight loss specifically it’s limited and shrinking. For example, Medi-Cal (California) stopped covering GLP-1 drugs for weight loss as of January 1, 2026, and MassHealth (Massachusetts) designated Wegovy and Saxenda as non-covered for treating overweight or obesity effective January 1, 2025. Non-weight-loss reasons may follow separate prior authorization rules, so check your state’s drug list.
CHAMPVA
CHAMPVA (the VA program for certain family members), which uses OptumRx, does not cover GLP-1 medications for weight loss. But it’s not a blanket Wegovy block: the VA says Wegovy may be covered for specific non-weight-loss reasons, such as reducing major adverse cardiovascular events or treating MASH. If you’re a CHAMPVA member, check the diagnosis-specific rule before assuming Wegovy is fully excluded.
Should I use Ro, Sesame, my doctor, or OptumRx directly?
Quick answer: Use OptumRx member services when you need plan-specific benefit details, your doctor when the prior authorization needs clinical evidence, Ro when you want help checking commercial coverage before you start, and Sesame when you want brand-name access with your choice of provider.
| Your situation | Best path | Why |
|---|---|---|
| You have a doctor and your app says “PA required” | Your doctor + OptumRx | Prescribers can submit the PA electronically with your clinical info |
| You have insurance but no clear answer yet | Ro’s free coverage check | Ro contacts your insurer and returns a coverage report with a copay estimate and PA needs |
| You want a provider to handle the PA for you | Ro Body membership | When a Ro-affiliated provider prescribes, Ro’s concierge submits the PA paperwork; membership is separate from medication |
| You want brand-name access and to pick your own provider | Sesame | Sesame lists the Wegovy pen and pill, lets you choose a provider, and offers Costco-member pricing |
| You have Medicare, Medicaid, TRICARE, or VA coverage | Your plan / CMS first | The savings card is off-limits for government plans, and Ro can’t coordinate government-plan coverage |
| You’re not sure which path fits | Our 60-second matcher | When you have several possible routes, a quick match beats guessing |
Two honest notes so you can choose with clear eyes:
Ro does not bill your insurance directly, and the membership is always cash. If your top priority is running everything through your insurance with zero out-of-pocket membership, a traditional in-network clinic plus your own pharmacy might suit you better. But because Ro skips insurance billing for the membership, its concierge can focus entirely on getting your medication covered — verifying benefits, submitting the PA, and resubmitting if you’re denied.
If that sounds like your situation, the lowest-commitment first step is the free coverage check — no membership required.
Before you chase coverage: what to know about Wegovy safety
Coverage is not the same as being a good fit.
Wegovy is a prescription medicine with real warnings, and a licensed clinician has to decide whether it’s right for you.
Per the FDA label, Wegovy carries a boxed warning about thyroid C-cell tumors seen in animal studies, and it should not be used by people with a personal or family history of medullary thyroid cancer or a condition called MEN2. The label also notes possible risks like dehydration-related kidney problems, gallbladder issues, pancreatitis, and serious allergic reactions, and it says Wegovy should not be used together with other semaglutide products or any other GLP-1 medication. Common side effects include nausea, diarrhea, and constipation, especially when starting or increasing the dose.
Getting Wegovy covered and being medically right for Wegovy are two different green lights. You need both.
Is compounded semaglutide the same as Wegovy?
No.
This page is about FDA-approved Wegovy, not compounded semaglutide — they are not the same thing, and we don’t treat them as interchangeable. The FDA says compounded drugs are not FDA-approved and don’t go through the same review for safety, effectiveness, and quality that approved drugs like Wegovy do, and it has warned consumers about illegally marketed, unapproved GLP-1 products sold online.
If your OptumRx plan won’t cover Wegovy, the cleanest FDA-approved cash-pay paths are the ones we listed above — NovoCare Pharmacy, TrumpRx, Costco/Sesame, or another licensed prescriber and pharmacy dispensing FDA-approved Wegovy — not unverified compounded products.
How we verified this OptumRx Wegovy guide
Quick answer: We checked official OptumRx, UnitedHealthcare, NovoCare, CMS, and FDA sources, and we kept three kinds of facts separate: plan/formulary facts, medical/regulatory facts, and our own editorial recommendations. Your final coverage and cost still have to be confirmed through your own OptumRx portal, plan documents, prescriber, or insurer.
Last verified: .
| What we verified | Source | Last checked |
|---|---|---|
| Wegovy listed Tier 2 with PA, QL, ++ | OptumRx 2026 formulary booklets | June 2026 |
| Meaning of PA, QL, ST, and ++ ("Benefit design options") | OptumRx formulary legend | June 2026 |
| Wegovy PA rules (BMI, lifestyle, 5-month initial, 5% renewal, CV, MASH, North Dakota) | UnitedHealthcare 2026 weight-loss PA program (effective 5/1/2026) | June 2026 |
| Savings card ($25/month) and self-pay pricing | NovoCare savings and pricing pages | June 2026 |
| Medicare GLP-1 Bridge ($50/month, three BMI pathways, July 2026 -- Dec 2027) | CMS Medicare GLP-1 Bridge | June 2026 |
| Wegovy indications and safety | FDA label (DailyMed) | June 2026 |
| Appeal timing (180 days) | HealthCare.gov and U.S. Department of Labor | June 2026 |
| Ro coverage check, concierge timing (1-3 weeks) | Ro insurance page | June 2026 |
OptumRx and Wegovy: Frequently Asked Questions
Does OptumRx cover Wegovy without prior authorization?
Usually no. On the OptumRx 2026 formularies we reviewed, Wegovy is listed with a 'PA' tag, which means prior authorization is required before the plan will cover it. Your prescriber has to submit clinical information first.
Why does OptumRx show Wegovy on a formulary but my plan says 'not covered'?
Because the formulary list is not the same as your specific benefit plan. OptumRx marks Wegovy with a '++' symbol, which it defines as 'benefit design options -- coverage is determined by your prescription medication benefit plan.' If your plan left weight-loss drugs off the benefit, the drug can be on the list and still not covered for you.
What BMI does OptumRx require for Wegovy?
For UnitedHealthcare commercial plans that cover weight-loss drugs, the 2026 criteria require a BMI of 30 or higher, or a BMI of 27 or higher with a weight-related condition like high blood pressure, high cholesterol, type 2 diabetes, or sleep apnea -- plus documented lifestyle effort. Your own plan's rules may differ, and North Dakota fully-insured plans require a BMI of 40 or higher.
How long does OptumRx approve Wegovy?
In the UnitedHealthcare criteria we reviewed, the initial Wegovy approval lasts 5 months. Renewal can be approved for 12 months if you show at least 5% weight loss from your starting weight and continue lifestyle changes.
What do I do if OptumRx denied my Wegovy prior authorization?
Get the denial reason in writing, save your denial documents, and compare the reason to your plan's criteria. If it's a fixable issue, your prescriber can resubmit. Federal rules generally give you 180 days from the denial notice to file an internal appeal.
Can I use the Wegovy savings card with OptumRx?
Possibly -- if you have eligible commercial (non-government) insurance that covers Wegovy. NovoCare says eligible patients may pay as little as $25 a month, with savings capped at $100 per monthly supply. Medicare, Medicaid, and TRICARE members can't use it.
Does Ro work with OptumRx?
Ro can help check your insurance coverage when you enter your card information, and it returns a personalized coverage report. When a Ro-affiliated provider writes your prescription through Ro Body, Ro's insurance concierge can also handle the prior authorization paperwork -- a process Ro says typically takes 1 to 3 weeks. Ro can't coordinate coverage through government plans like Medicare or Medicaid.
Does OptumRx cover the Wegovy pill?
Some criteria we reviewed include both the Wegovy injection and the Wegovy tablet, but your own plan has to confirm whether the pill, the pen, or both are covered. Coverage can differ by form and dose.
Is Wegovy covered if I don't have diabetes?
Wegovy isn't a diabetes drug the way Ozempic is. Its FDA-approved uses include chronic weight management, cardiovascular risk reduction in adults with established heart disease who are overweight or obese, and -- for the Wegovy injection -- noncirrhotic MASH with F2-F3 fibrosis. Coverage still depends on your plan's rules, not on whether you have diabetes.
Should I switch plans during open enrollment to get Wegovy?
Only after you verify the exact drug coverage, prior authorization rules, any required programs, and your expected out-of-pocket cost for the new plan. A plan that says 'covered with PA' can still deny the medication if you don't meet the criteria or a plan-sponsor requirement. Get the coverage promise in writing before you switch.
Still not sure which GLP-1 program is right for you?
Take our free 60-second matching quiz. We’ll point you to the path that fits your insurance, your budget, and your goals — whether that’s pushing your OptumRx prior authorization through, appealing a denial, or finding the cheapest FDA-approved cash option.
Take our free 60-second GLP-1 matching quiz
Get a personalized action plan based on your insurance, your situation, and your goals.
Take the free 60-second GLP-1 matching quiz →Related guides
Sources we checked
- OptumRx — 2026 Select Standard and standard formulary booklets, including the symbol legend (PA, QL, ST, ++)
- UnitedHealthcare — 2026 Prior Authorization/Notification: Plans with Weight Loss/Appetite Suppression Medication Coverage (effective May 1, 2026)
- OptumRx — Know Your Coverage and Costs (member resources)
- NovoCare — Wegovy Savings Offer and self-pay pricing
- CMS — Medicare GLP-1 Bridge: Information for Beneficiaries
- DailyMed — Wegovy (semaglutide) injection and tablet label
- HealthCare.gov — internal appeals; U.S. Department of Labor — filing a health benefits claim
- CVS Health — GLP-1 weight management coverage update (May 2026)
- Ro — Weight Loss Program and Insurance; Eli Lilly — Foundayo (orforglipron) FDA approval (April 2026)
Last updated: . Last verified: . The RX Index Editorial Team.